A platform allows to compare embryos for health and intelligence. It does not offer guarantees

Choosing the features of a baby as if they were the video game editor is something that has been explored in science fiction. Films like ‘The sixth day‘ either ‘Gattaca‘They have this implicit practice by manipulating genetic elements at pleasure in the Human cloning process. As usual, reality surpasses fiction and, a few weeks ago, the Nucleus genomics company launched Embryo, a software to compare embryos and that parents have All the information of your DNA. From diseases that can develop to hair color, height … or intelligence. ITV before existing. Embryo is a platform. It loads the DNA data without processing up to 20 embryos to elaborate a genetic profile with a luxury detail. They do not perform this sequencing, but obtain it from files provided by clinics of In vitro fertilization, or IVF. What they do is apply polygenic prediction models (a technique that takes the variants in the genome to estimate the risk that a person develops a physical disease or feature) to offer parents a report in which both health and health features are evaluated. Eliminating risks. According to the company, they can filter more than 900 hereditary diseases and more than 40 additional characteristics such as chronic diseases. Thus, parents can compare, classify and select the best embryos based on genetic profiles, filtering retail risk to subsequently perform IVF. It They qualify As “the first genetic optimization software” and the truth is that the interface is the most striking because, at a glance, we have a lot of variants and elements with which to compare embryos, as well as a filter system to perform a faster search of the feature that interests us most. Personalization in detail. But, as can be seen in the image, not only the diseases and the probability of developing others such as the Parkinson or the Alzheimer’sbut also physical features. Eye color, hair, the probability of being overweight and even cognitive capacity. Specifically, and as we can see in your paragraph of “questions and answers”, this is what allows you to see the database you create: Appearance and features: Eye color, height, hair color, male pattern and severe acne. Body and Physical Health: Body mass index (BMI), chronic pain, zurdera, osteoarthritis and rheumatoid arthritis. Women’s health: Endometriosis, polycystic ovary syndrome (SOP). Nutrition and metabolic conditions: Alcohol dependence, celiac disease and type 2 diabetes. Cardiac health: Coronary arteria disease or hypertension. Cancers: Breast cancer, male breast cancer, ovarian cancer, gastric cancer, prostate cancer and colorectal cancer. Neurological and mental health: ADHD, Alzheimer’s, anxiety, bipolar disorder, depression, insomnia, migraine, multiple sclerosis, Toc, Parkinson’s disease, schizophrenia and intelligence. Hereditary disorders: More than 900 hereditary diseases, including rare conditions such as cystic fibrosis and hemochromatosis, if a complete genome file is loaded. Other conditions: Asthma, macular degeneration associated with age, restless legs syndrome and seasonal allergies. The controversy. In these weeks after the launch, Embyo’s report and service has been considered a revolutionary element in assisted reproduction due to the wide range of options and details it offers. But, although there are voices that defend it due to the role it can play in disease prevention, there are also critics They argue that selecting non -medical features, such as appearance or cognitive abilities, raises doubts and sows the seed of the marketing of embryonic selection. The company’s response, of his CEO Kian Sadeghi, specifically, is forceful and quite aggressive. In it release released for the launch of the service, he affirms the following: “One more thing: some people believe you should not have access to what Nuleus Embyo allows you to do. Here is the thing: it is not your choice, but yours.” The price. At the moment, Nucleus is only available In the United States, but there is a waiting list for the international launch, and although there are several tests that the company sells to have different types of information about our DNA, the Embryo Service that analyzes all the parameters we have spoken costs $ 5,999, such as Sadeghi confirmed to WSJ. Limited guarantee. The idea is that technology is becoming more accessible as this service is implemented directly in the clinics offered by IVF, but for now, they sell “science as a superpower” and claim to have arrived to “change lives.” Now, $ 6,000 do not ensure that, when choosing everyone’s best embryo, things cannot happen in the future. As they point out in their FAQ, “DNA does not mark destiny” and there is much that we do not know about how DNA shapes those who end up being. “Genetics can be a useful tool to choose an embryo, but it is not a guarantee,” they say. “In addition to genetics, environmental factors, lifestyle decisions and other factors significantly influence both the chances of a person developing a condition and who will become.” And the truth is that, however ambitious it is Embyo, it is a technology that is not new and a few years ago we talk about how this practice I might have no real impact. Images | Mynucleus In Xataka | In New Zealand they will try to resurrect extinction to a kind of three -meter kiwi. And all thanks to Peter Jackson

Anthropic possibly has the best generative product. And not even that guarantees that it survives

AI is an unprecedented money devouring. Anthropic is closing a round of 3.5 billion dollars that triggers its valuation to more than 61,000 million. An astronomical figure for a company with a produce … but that has barely two million monthly active users. And projected income of “only” 1.2 billion for this year. The numbers do not add up. And that is precisely the issue. Anthropic’s problem is not the quality of your product. Claude is, in many ways, the most refined market assistant. His security approach and greater ethics, his warmer communication – as warm is his background color as opposed to Chatgpt nuclear – and his ability to hold coherent and deep conversations have made him the favorite of many demanding users. It is really good. But being the best does not assure you victory in the technology industry. Not even survival. OpenAi has 400 million active weekly users because a bestial brand has been built in AI. Google has a kind of Klapauciusan infinite money trick thanks to Your advertising empire. XAI of Elon Musk takes advantage of the X platform and its own CEO as natural showcases. Microsoft has integrated AI throughout its product ecosystem. And Anthropic? It has a great product with little distribution. It is the perfect paradox: the best assistant that almost nobody uses. The history of technology is full of higher products that ended up losing in front of mediocre but better positioned rivals. Betamax was technically superior to VHS. Apple’s Newton anticipated the iPhone for a while but a chestnut was given. Netscape Domino Internet Before being crushed by Internet Explorer. What we are witnessing is A classic standard warwhere the winner will not necessarily be the best product, but that he achieves the critical mass necessary to establish himself as the new standard of the industry. The uncomfortable reality is that we live in a world, As my said yesterday quate Javier Pastorwith Too many models of AI. Every week a new one arises. Anthropic, Openai, Google, Microsoft, Meta, XAI, Deepseek, Perplexity, Mistral, Alibaba … the list continues to grow. And when the risk capital stops flowing so generously – because at some point it will – many will not survive. The analyst Ed Zitron expresses it bluntly: Anthropic “is not a real company, I could not survive without the beneficence of risk capital.” With losses of 5,600 million last year, it is difficult to refute that statement. Zitron omits that living in losses seized to risk capital is the routine of much of the technological industry, but it is not reason. Anthropic’s strategy seems clear: to position itself as the “most human” alternative against the energy of “Robot God” of Openai. Your demos They include warm color corrections, relaxing jazz music and presenters who sound like normal people speaking normal, not as a Chief of or a Head of proclaiming achievements. It is an intelligent approach. Is it enough? Perhaps the most likely destiny for Anthropic is the acquisition. An excellent product with scarce commercial traction is attractive to giants that seek to improve their own AI offers. Apple, who has not yet shown all its cards in this game, could be a logical buyer, although its shopping history is far from these quantities: its greatest acquisition was that of Beats eleven years ago and paid for it twenty times less than what Anthropic is worth now. In this landscape oversaturated with almost indistinguishable models for the average user, the question is not who has the best technology, but who will survive when the money of the venture capital begins to scarce. And in that battle, having the best product is surely not enough. In Xataka | The new Claude 3.7 of Anthropic simplifies what other models complicate. And incidentally program and “reason” like the best Outstanding image | Anthropic

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.